Spontaneous reactivation of hepatitis B virus with multiple novel mutations in an elderly patient with resolved hepatitis B virus infection.
Tokio SasakiKeisuke KakisakaAkio MiyasakaMasao NishiyaNaoki YanagawaHidekatsu KurodaTakayuki MatsumotoMasaharu TakahashiHiroaki OkamotoPublished in: Clinical journal of gastroenterology (2024)
Spontaneous reactivation of the Hepatitis B virus (HBV) is rare in individuals with previously resolved infections. This report presents the case of a 71 year-old Japanese woman who experienced HBV reactivation without any prior immunosuppressive therapy or chemotherapy. Before the onset of liver injury, the patient was negative for hepatitis B surface antigen (HBsAg) but positive for hepatitis B surface antibody. She subsequently developed liver injury, with the reappearance of HBsAg and HBV DNA. The patient was successfully treated with tenofovir alafenamide, and prednisolone. Full-genome sequencing of HBV revealed subgenotype B1 without hepatitis B e-negative mutations in the precore and core promoter regions and 12 amino acid alterations in the pre-S1/S, P, and X genes. Notably, the S gene mutations D144A and K160N, which alter the antigenicity of HBsAg and potentially contribute to its reactivation, were identified. This case emphasizes the importance of vigilance for spontaneous reactivation of resolved HBV, highlighting the need for comprehensive genomic analysis to understand the associated virological intricacies.
Keyphrases
- hepatitis b virus
- liver injury
- drug induced
- case report
- liver failure
- genome wide
- dna methylation
- single cell
- antiretroviral therapy
- squamous cell carcinoma
- stem cells
- radiation therapy
- single molecule
- transcription factor
- smoking cessation
- mesenchymal stem cells
- cell therapy
- middle aged
- cell free
- rectal cancer
- replacement therapy
- genome wide identification